# Docosahexaenoic Acid Supplementation in Postnatal Growth Restricted Rats Does Not Normalize Lung Function or PPARγ Activity

**Authors:** Adrienne J. Cohen, Wesley R. Chidester, Daniel T. Wray, Nicolette Jessen, Aimee Jones, Cheylah Bitsui, James Zhao, J. Alan Maschek, James E. Cox, Camilia R. Martin, Lisa A. Joss-Moore

PMC · DOI: 10.3390/biom15040551 · Biomolecules · 2025-04-09

## TL;DR

This study finds that adding DHA to the diet of growth-restricted rat pups does not improve lung function or PPARγ activity, which could explain why some preterm babies have poor lung outcomes.

## Contribution

The study demonstrates that DHA supplementation in growth-restricted rats does not normalize lung function or PPARγ activity, suggesting potential risks in clinical use.

## Key findings

- PPARγΔ5 is expressed in the developing rat lung.
- DHA supplementation alters global circulating fatty-acid profiles in growth-restricted rats.
- DHA supplementation does not normalize impaired lung mechanics or PPARγ activity in growth-restricted rats.

## Abstract

The development of BPD in preterm neonates is increased by poor growth and nutritional deficits. The involvement of the fatty acid DHA in the development of BPD has been a focus for over a decade. However, recent clinical trials show that isolated DHA supplementation may increase BPD in subgroups of preterm neonates. One explanation for poor lung outcomes in DHA-supplemented neonates is a disruption of global fatty acid profiles and increased expression of a dominant-negative splice variant of a key driver of lung development, PPARγ. We previously developed a rat model of postnatal growth restriction (PGR) in which pups have impaired lung function and altered PPARγ activity. Here, we use our PGR rat model to assess the effects of DHA supplementation on lung outcomes. We hypothesize that the PPARγ splice variant, PPARγΔ5, will be expressed in the rat lung, and that DHA supplementation of PGR rat pups will alter circulating lipid profiles, lung mechanics, and PPARγ variant expression. Our findings demonstrate that PPARγΔ5 is expressed in the developing rat lung and that DHA supplementation of PGR rat pups alters global circulating fatty-acid profiles and does not normalize PGR-induced impaired lung mechanics or PPARγ activity.

## Linked entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468]
- **Chemicals:** DHA (PubChem CID 15608515), docosahexaenoic acid (PubChem CID 445580)
- **Diseases:** BPD (MONDO:0001156)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Pparg (peroxisome proliferator-activated receptor gamma) [NCBI Gene 25664] {aka PPARgamma2}
- **Diseases:** Growth (MESH:D006130), nutritional deficits (MESH:D009748), growth restriction (MESH:D005317), impaired lung function (MESH:D003072)
- **Chemicals:** lipid (MESH:D008055), fatty acid (MESH:D005227), DHA (MESH:C027493), Docosahexaenoic Acid (MESH:D004281)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12024927/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12024927/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12024927/full.md

---
Source: https://tomesphere.com/paper/PMC12024927